Navigation Links
P&G Reports $0.98 EPS, Up 17%, on 9% Sales Growth; Announces Plan to Create Stand-Alone Coffee Company
Date:1/31/2008

tion of exchanging their P&G shares for shares in the newly formed coffee company.

Assuming a split-off, the company expects the deal to be dilutive to EPS by 3 to 5 cents on an annual basis. Also, a split-off transaction would result in a significant one-time gain which would be partially offset by one- time transition costs and a one-time increase in restructuring spending associated with eliminating stranded overhead costs and offsetting EPS dilution.

P&G expects to determine the final deal structure during the April-June 2008 quarter and complete the transaction during the July-December 2008 period. P&G said the deal structure will be dependent on market conditions, and P&G will execute the transaction only if it achieves sufficient market valuation.

"We greatly appreciate the contributions of our Coffee employees. For over 45 years the Coffee business has been an important contributor to the success of Procter and Gamble," said Mr. Lafley. "This separation allows us to focus on our core businesses and The Folgers Coffee Company to further develop and leverage its brand portfolio in a coffee-specific business model."

Key Financial Highlights

Net sales for the quarter increased nine percent to $21.6 billion behind five percent volume growth and a five point favorable foreign exchange impact. Disproportionate growth in developing regions resulted in a negative one percent mix impact. Organic sales were up five percent behind six percent organic volume growth. Growth was driven by continued success on initiative activity across the company. A number of the company's key brands, including Duracell, Febreze, Fusion, Head & Shoulders, Nice 'N Easy, Pampers, Prilosec and Tide, delivered double-digit volume growth.

Diluted net earnings per share increased 17 percent to $0.98. Net earnings increased 14 percent to $3.3 billion behind higher sales growth, increased operating profit and a lower tax rate. Operating margin was down sl
'/>"/>

SOURCE The Procter & Gamble Company
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19

Related medicine news :

1. Nutraceutical Reports Fiscal 2008 Q1 Results
2. Matrixx Initiatives, Inc. Reports Fiscal 3rd Quarter Net Sales of $30.8 Million and Net Loss of ($0.07) Per Share
3. Accuray Reports Continued Growth in Second Quarter of Fiscal 2008
4. Cardinal Health Reports Second Quarter Results, Revises EPS Outlook
5. Encision Reports Third Fiscal Quarter Results
6. Zimmer Reports Fourth Quarter and 2007 Financial Results
7. Amylin Pharmaceuticals Reports 2007 Financial Results
8. Cystic Fibrosis Foundation reports upward trend for key health outcomes
9. NBTY Reports First Quarter Results
10. Moog Reports 14% Increase in Earnings Per Share
11. Kensey Nash Reports Second Quarter EPS of $0.21 and Revenue of $19.6 Million

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/21/2009)..., , "This bill provides for an unprecede...is health care about if it is not for preserving a...ed, it must be defeated." Charmaine Yoest ,,...ericans United for Life Action President and CEO D...the Senate by releasing the following statement: ...
(Date:11/21/2009)..., , LONDON, November 21, 2009 /PRNewswire-...est Test Test Test Test Test Test Test Test Test T...est Test Test Test Test Test Test,Test Test Test T... More test More test More test More test More ...test More test More test More test More test More,...
(Date:11/21/2009)... Eric J. Hall, president an...ation of America (AFA) issued the following statem...t detection as part of the new annual wellness for...ction and Affordable Care Act" that was intro...ork, NY (PRWEB) November 21, 2009 -- Eric J. Hall,...
(Date:11/20/2009)..., , PRINCETON, NJ, Nov. 20 /PRNewswire-First...day that a Special Meeting of Shareholders will be... the Meeting is to consider approval of two specia...approve and authorize the sale of all or substanti...n the terms provided for in the asset purchase agr...
(Date:11/20/2009)... Senators and Congressmen i...ble Over their Health Care Vote , ...-- Senators and congressmen running for re-electio...olitical guru Charlie Cook, may come to regret vot...care bill, according to a breaking Zogby Internati...
Breaking Medicine News(10 mins):Health News:Leading Anti-Abortion Group Vows to Vigorously Fight the Senate Health Bill 2Health News:Alzheimer's Foundation of America Applauds Inclusion of Cognitive Impairment Detection in Healthcare Reform 2Health News:Alzheimer's Foundation of America Applauds Inclusion of Cognitive Impairment Detection in Healthcare Reform 3Health News:NUCRYST Announces Special Meeting of Shareholders 2Health News:NUCRYST Announces Special Meeting of Shareholders 3Health News:Just 25% of Voters in Competitive 2010 Senate Races “Much More Likely” to Support Pelosi-Democrats Who Voted for Health Care Bill 2Health News:Just 25% of Voters in Competitive 2010 Senate Races “Much More Likely” to Support Pelosi-Democrats Who Voted for Health Care Bill 3
...son Introduces Docuscan Patient History System Wit...logy, BLOOMINGTON, Minn., Sept. 4 Today Pearson ...new innovative solution for,digitally capturing pa...Paros(TM) technology enables,digital capture of pa...
...IGH, N.C., Sept. 4 MedThink Communications, an,in...elations, has been,retained by NanoBio Corporation...zed particles to eradicate skin infections, withou...nd medical,communications in order to advance Nano...
...he next battle in the war on asthma symptom contro... , It turns out that Mom and Dads leeriness towar...king theyre not essential, or believing they pose ...e-breathing disease do not take their prescription...
...he Healthy Steps for Young Children Program, which...ric practices, continued to benefit families more ...ding to a study by researchers from the Johns Hopk...ir childs health care, greater odds that parents w...
...isition of Consultech Strengthens Omnicom,s Presen...althcare Market, BEIJING, Sept. 3 Omnicom Group ... advertising and marketing,services group, has acq...nd marketing communications company based in,China...
... In this weeks press release: , , Renal functio...-induced acute lung injury in mice by mesenchymal ...ease mention PLoS Medicine in your report and use ...ction and coronary heart disease , , John Danesh ...
Other Medicine News:Health News:New 'Smart' Technology Makes Patient Data Collection Easier, More Efficient 2Health News:MedThink Communications Retained by NanoBio Corporation 2Health News:Parents' perceptions can hamper kids' asthma care, study finds 2Health News:Parents' perceptions can hamper kids' asthma care, study finds 3Health News:Practice-based intervention has sustained benefits for children and families 2Health News:Omnicom Acquires Leading Healthcare Marketing Communications Firm in China 2Health News:Omnicom Acquires Leading Healthcare Marketing Communications Firm in China 3Health News:Renal function and heart disease, and more 2
(Date:11/20/2009)...wswire-FirstCall/ -- Soligenix, Inc. (OTC Bulletin... known as DOR BioPharma, Inc., a late-stage biotec...d a consortium to develop thermostable technology ...ines. Soligenix received a $9.4 million grant from...Diseases (NIAID), a division of the National Insti...
(Date:11/19/2009)...ewswire-FirstCall/ -- BioCryst Pharmaceuticals, In... a public offering of 5,000,000 shares of its comm...oceeds of $48.75 million. All of the shares are b...shelf registration statement previously filed with... has also granted the underwriters a 30-day option...
(Date:11/19/2009)...wswire-FirstCall/ -- In a series of new initiative...oration (Nasdaq: HSKA ) ("Heska" or the "Company"...ed website. The upgraded site is the result of se...o align the site with the company,s new brand imag.../www.newscom.com/cgi-bin/prnh/20000622/HESKALOGO )...
Breaking Medicine Technology:Soligenix Forms Consortium to Develop Thermostable Technology to Advance RiVax(TM) and Other Rapidly Acting Vaccines 2Soligenix Forms Consortium to Develop Thermostable Technology to Advance RiVax(TM) and Other Rapidly Acting Vaccines 3Soligenix Forms Consortium to Develop Thermostable Technology to Advance RiVax(TM) and Other Rapidly Acting Vaccines 4Soligenix Forms Consortium to Develop Thermostable Technology to Advance RiVax(TM) and Other Rapidly Acting Vaccines 5Soligenix Forms Consortium to Develop Thermostable Technology to Advance RiVax(TM) and Other Rapidly Acting Vaccines 6BioCryst Announces Pricing of Public Offering of Common Stock 2BioCryst Announces Pricing of Public Offering of Common Stock 3Heska Announces Launch of New Website 2Heska Announces Launch of New Website 3Accumetrics VerifyNow 28R 29 P2Y12 Test Provides Physicians With Information to Assess a Patients Response to Newly Approved Prasugrel 28Effient 28R 51616 1Accumetrics VerifyNow 28R 29 P2Y12 Test Provides Physicians With Information to Assess a Patients Response to Newly Approved Prasugrel 28Effient 28R 51616 2Get the Most Out of Your Run 51614 1Get the Most Out of Your Run 51614 2Get the Most Out of Your Run 51614 3Increase in Thyroid Cancer Puzzles Experts 51611 1Increase in Thyroid Cancer Puzzles Experts 51611 2
Universal Facial Wrap
Facial Mask
Abdominal Binders - 9" & 12"
Abdominal Girdle V-840
Medicine Products: